Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alcoholic Fatty Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05962099
What this trial is testing

Defining Circadian Metabolism in Non-alcoholic Fatty Liver Disease

Who this might be right for
NAFLD
University of Oxford 31
Testing effectiveness (Phase 2)Study completedNCT06297434
What this trial is testing

Phase 2a Study to Evaluate Safety and Explore Efficacy of J2H-1702 for NASH

Who this might be right for
Non-alcoholic Steatohepatitis
J2H Biotech 87
Not applicableLooking for participantsNCT06206616
What this trial is testing

Liver Steatosis in Pediatric CD Patients

Who this might be right for
Celiac Disease in ChildrenNon-Alcoholic Fatty Liver Disease
University of Palermo 91
Not applicableUnknownNCT04664036
What this trial is testing

Prevalence, Incidence and Characteristics of NAFLD/NASH in Type 1 Diabetes Mellitus

Who this might be right for
NAFLDType 1 DiabetesCardiovascular Diseases
University Hospital, Antwerp 700
Not applicableUnknownNCT01705522
What this trial is testing

Multimodal Approach in IBD Patients

Who this might be right for
Ulcerative ColitisCrohn's DiseaseNonalcoholic Fatty Liver Disease (NAFLD)+1 more
Clinical Hospital Colentina 50
Testing effectiveness (Phase 2)Study completedNCT03350165
What this trial is testing

Pemafibrate in Patients With Nonalcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Kowa Company, Ltd. 118
Not applicableStudy completedNCT01834300
What this trial is testing

The Effect of Exercise Intervention on Insulin Resistance in Non-alcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Non Alcoholic Fatty Liver Disease
University of Liverpool 60
Large-scale testing (Phase 3)Active Not RecruitingNCT03900429
What this trial is testing

Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Madrigal Pharmaceuticals, Inc. 1,759
Not applicableStudy completedNCT00889577
What this trial is testing

Coronary Artery Disease and Its Association With Liver Steatosis Among HIV-Infected Persons

Who this might be right for
HIV InfectionsCoronary Artery DiseaseNon-Alcoholic Fatty Liver Disease
Henry M. Jackson Foundation for the Advancement of Military Medicine 233
Testing effectiveness (Phase 2)Study completedNCT02279407
What this trial is testing

Investigate Effects of Omega-3 Carboxylic Acids and Dapagliflozin on Liver Fat Content in Diabetic Patients

Who this might be right for
T2 Diabetes and Fatty Liver Disease (Non-alcoholic Origin)
AstraZeneca 223
Testing effectiveness (Phase 2)Study completedNCT04321395
What this trial is testing

Vigabatrin and Insulin Sensitivity

Who this might be right for
NAFLDObesity
Washington University School of Medicine 4
Not applicableStudy completedNCT04571957
What this trial is testing

Expanding Donor Pool for Live Donor Liver Transplantation: Utilization of Donors With NASH After Optimization

Who this might be right for
Non Alcoholic Steatohepatitis
Institute of Liver and Biliary Sciences, India 410
Testing effectiveness (Phase 2)Study completedNCT01759628
What this trial is testing

Helicobacter Pylori Eradication in Subjects With Non-alcoholic Fatty Liver Disease

Who this might be right for
Non-alcoholic Fatty Liver Disease
Tehran University of Medical Sciences 100
Not applicableUnknownNCT05217745
What this trial is testing

MLCT Oil for Fatty Liver - PASS Trial

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNon-Alcoholic SteatohepatitisNAFLD
National University Hospital, Singapore 30
Post-approval studies (Phase 4)Study completedNCT05459701
What this trial is testing

Dapagliflozin in Type 2 Diabetes Mellitus Patients (T2DM) With Nonalcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Nonalcoholic Fatty Liver DiseaseType 2 Diabetes
Rehab Werida 50
Not applicableStudy completedNCT06024681
What this trial is testing

Impact of FMT on the Phenome in Patients With NAFLD and Fibrosis

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseFecal Microbiota Transplantation
Imperial College London 16
Not applicableUnknownNCT04298736
What this trial is testing

Bariatric Surgery vs. Lifestyle Modification for NASH

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Hospital de Clinicas de Porto Alegre 50
Not applicableUnknownNCT02083159
What this trial is testing

C1q/TNF-related Proteins in Non-Alcoholic Fatty Liver Disease

Who this might be right for
NAFLD
Korea University 500
Testing effectiveness (Phase 2)Looking for participantsNCT07288138
What this trial is testing

A Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)

Who this might be right for
Metabolic Dysfunction-associated Steatohepatitis
Eccogene 160
Not applicableStudy completedNCT00868933
What this trial is testing

Low Glycemic Index Dietary Intervention Program in Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver Disease
Chinese University of Hong Kong 159
Next Page